INVO Fertility (IVF) Capital Expenditures (2016 - 2025)

INVO Fertility (IVF) has 9 years of Capital Expenditures data on file, last reported at $8062.0 in Q3 2025.

• Capital Expenditures for Q3 2025 came in at $8062.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2025 was $110463.0 (down 38.57% YoY), and the FY2024 annual result was $183703.0, down 58.69% from the prior year.
• Capital Expenditures eased to $8062.0 in Q3 2025 per IVF's latest filing, from $8877.0 in the prior quarter.
• Over five years, Capital Expenditures peaked at $108217.0 in Q3 2023 and troughed at -$328537.0 in Q4 2021.
• A 5-year average of $6212.1 and a median of $8877.0 in 2025 frame the typical range for Capital Expenditures.
• The sharpest annual moves came in 2021 and 2023: Capital Expenditures sank 1519.37% in 2021, then jumped 55655.56% in 2023.
• A 5-year view of Capital Expenditures shows it stood at -$328537.0 in 2021, then jumped by 99.96% to -$135.0 in 2022, then jumped by 55655.56% to $75000.0 in 2023, then grew by 5.17% to $78874.0 in 2024, then sank by 89.78% to $8062.0 in 2025.
• Business Quant data shows IVF's Capital Expenditures at $8062.0 in Q3 2025, $8877.0 in Q2 2025, and $14650.0 in Q1 2025.